CaSfA - Cancer Support for All
News from CaSfA's Director

March 2014

Immune-System Based Therapy for Metastatic Melanoma

Big news from Dana Farber: Treatment of patients with metastatic melanoma treated with a new immune system-based therapy has produced lasting remissions!!  The drug, Nivolumab worked for many patients after other treatments failed.
Here’s the article about Nivolumab from Dana Farber’s news release:
Website Builder provided by  Vistaprint